1-9 of 9
A Hagenbeek
Close
Sort by
Journal Articles

HuMax-CD20, a Novel Fully Human Anti-CD20 Monoclonal Antibody: Results of a Phase I/II Trial in Relapsed or Refractory Follicular Non-Hodgkins’s Lymphoma.

A. Hagenbeek, T. Plesner, P. Johnson, L. Pedersen, J. Walewski, A. Hellmann, B. Link, T. Robak, M. Wojtukiewicz, M. Pfreundschuh, M. Kneba, A. Engert, P. Sonneveld, J. Petersen, J. Radford
Journal: Blood
Blood (2005) 106 (11): 4760.
https://doi.org/10.1182/blood.V106.11.4760.4760
Published: 2005
Journal Articles

Assessing the Predictive Value of Plasma FLT3-L Levels for Hematologic Toxicity after Yttrium-90 Ibritumomab Tiuxetan ([ 90 Y]-Zevalin) Given as Consolidation in Patients with Advanced B-Cell Follicular NHL Responding to First Line Therapy.

F. Morschhauser, J. Radford, A. van Hoof, I. Kuss, A. Chlistalla, A. Hagenbeek
Journal: Blood
Blood (2005) 106 (11): 4795.
https://doi.org/10.1182/blood.V106.11.4795.4795
Published: 2005
Journal Articles

The International Prognostic Index Correlates to Survival in Patients With Aggressive Lymphoma in Relapse: Analysis of the PARMA Trial

J.-Y. Blay, F. Gomez, C. Sebban, T. Bachelot, P. Biron, C. Guglielmi, A. Hagenbeek, R. Somers, F. Chauvin, T. Philip
Journal: Blood
Blood (1998) 92 (10): 3562–3568.
https://doi.org/10.1182/blood.V92.10.3562
Published: 1998
Journal Articles

Clinical analysis of 670 cases in two trials of the European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group subtyped according to the Revised European-American Classification of Lymphoid Neoplasms: a comparison with the Working Formulation

S Pittaluga, L Bijnens, I Teodorovic, A Hagenbeek, JH Meerwaldt, R Somers, J Thomas, EM Noordijk, C De Wolf-Peeters
Journal: Blood
Blood (1996) 87 (10): 4358–4367.
https://doi.org/10.1182/blood.V87.10.4358.bloodjournal87104358
Published: 1996
Journal Articles

Effect of ultraviolet-B light on lymphocyte activity at doses at which normal bone marrow stem cells are preserved

H Gowing, M Lawler, A Hagenbeek, SR McCann, DH Pamphilon, J Hudson, H van Weelden, E Braakman, AC Martens
Journal: Blood
Blood (1996) 87 (4): 1635–1643.
https://doi.org/10.1182/blood.V87.4.1635.bloodjournal8741635
Published: 1996
Journal Articles

Parma international protocol: pilot study of DHAP followed by involved- field radiotherapy and BEAC with autologous bone marrow transplantation

T Philip, F Chauvin, J Armitage, D Bron, A Hagenbeek, P Biron, G Spitzer, W Velasquez, DD Weisenburger, J Fernandez-Ranada
Journal: Blood
Blood (1991) 77 (7): 1587–1592.
https://doi.org/10.1182/blood.V77.7.1587.1587
Published: 1991
Journal Articles

Bivariate flow karyotyping in human Philadelphia-positive chronic myelocytic leukemia

GJ Arkesteijn, AC Martens, A Hagenbeek
Journal: Blood
Blood (1988) 72 (1): 282–286.
https://doi.org/10.1182/blood.V72.1.282.282
Published: 1988
Journal Articles

Nonhomogeneous distribution of leukemia in the bone marrow during minimal residual disease

AC Martens, FW Schultz, A Hagenbeek
Journal: Blood
Blood (1987) 70 (4): 1073–1078.
https://doi.org/10.1182/blood.V70.4.1073.1073
Published: 1987
Journal Articles

High-dose methotrexate with leucovorin rescue: effectiveness in relapsed hairy cell leukemia

P Joosten, A Hagenbeek, B Lowenberg, W Sizoo
Journal: Blood
Blood (1985) 66 (1): 241–242.
https://doi.org/10.1182/blood.V66.1.241.241
Published: 1985